HCC Screening
Blog Who Should Get HCC Screening? Who Should Get HCC Screening? People with certain liver disease risk factors should discuss hepatocellular carcinoma (HCC) screening with a healthcare professional. This often includes patients with cirrhosis, hepatitis B or C, NAFLD/NASH, alcohol‑related liver disease, or a family history of liver cancer. If you fall into one of these groups, […]
HCC Blood Test Vs Ultrasound
Blog HCC Blood Test Vs Ultrasound You have liver cirrhosis. Or hepatitis C. Or fatty liver disease. Your physician has told you to get screened for liver cancer. And then comes the question nobody quite explains clearly enough: Which screening approach is actually better — a blood test or an ultrasound? The honest answer is […]
Liver Cancer Tumor Markers
Blog Liver Cancer Tumor Markers For decades, the search for liver cancer has relied heavily on a single protein in the blood. That protein — alpha-fetoprotein, or AFP — became the standard marker used to monitor patients at risk for hepatocellular carcinoma. Clinicians measured it, guidelines recommended it, and patients were told a normal result […]
Can Liver Cancer Be Detected By Blood Test?
Blog Can Liver Cancer Be Detected By Blood Test? Here is a question thousands of Americans with chronic liver disease type into Google every month — and the answer matters more than most people realise. If you have cirrhosis, hepatitis B or C, or fatty liver disease, your risk of developing hepatocellular carcinoma (HCC) is […]
Liver Cancer Screening At Home
Blog Liver Cancer Screening At Home Most people at high risk for liver cancer already know they should be screened. They have cirrhosis, hepatitis B or C, or fatty liver disease. Their physician has mentioned monitoring. They understand the stakes. And yet — they do not get screened. Not because they do not care. Because […]
Cirrhosis And Liver Cancer Screening
Blog Cirrhosis And Liver Cancer Screening Cirrhosis is one of the most important risk factors for hepatocellular carcinoma. People living with cirrhosis should discuss liver cancer screening with a healthcare professional and understand which tools may be appropriate for their situation. Why Cirrhosis Increases Liver Cancer Risk Cirrhosis is the advanced scarring of liver tissue […]
Early Liver Cancer Detection
Blog Early Liver Cancer Detection Early liver cancer detection matters because hepatocellular carcinoma is often found after symptoms appear. For people with known risk factors, regular screening and timely follow-up can help identify concerns earlier and guide next steps with a physician. Why Early Detection Matters Hepatocellular carcinoma (HCC) is one of the most survivable […]
Liver Cancer Blood Test For Early HCC Screening
Blog Liver Cancer Blood Test For Early HCC Screening A liver cancer blood test may help support screening conversations for people at higher risk of hepatocellular carcinoma (HCC), the most common type of primary liver cancer. MoleculeDx focuses on blood‑based testing for early liver cancer detection and is designed to help eligible patients and providers take the next step […]
HCC Screening Test For High-Risk Patients
Blog HCC Screening Test For High-Risk Patients An HCC screening test is used to help monitor people who may be at increased risk of hepatocellular carcinoma — the most common form of primary liver cancer. MoleculeDx provides blood-based testing support for eligible patients as part of a physician-guided screening and follow-up conversation. What Is HCC? Hepatocellular […]
Why AFP Tests Miss Liver Cancer in Half of Patients
Blog Why AFP Tests Miss Liver Cancer in Half of Patients The challenge is not a lack of will. It is a lack of accurate tools. One of the biggest problems is our continued reliance on alpha‑fetoprotein (AFP) testing—a marker that has been used for decades despite one critical flaw: it misses liver cancer in […]